Privia Health Group (PRVA) risk factors, FY2025 10-K

Other

1. 01collective action to set commercial payer reimbursement rates, and establish integration requirements (financial risk or clinical integration) for joint ventures or healthcare networks to jointly contract with payersNew
2. 02Our business model relies on a complex legal framework that governs our relationships with Medical Groups and Privia Providers. Legal challenges or shifting interpretations of applicable laws could require us to make significant changes to our operations, which could adversely affect our business
3. 03Our business, financial condition and results of operations may be adversely affected by changes and uncertainty in the healthcare industry, including health reform initiatives and other changes to laws and regulations34% rewritten
4. 04We, our Medical Groups and Privia Providers, may be subject to legal proceedings, including litigation, governmental investigations and claims, and payer audits64% rewritten
5. 05bring whistleblower lawsuits against companies that allegedly submit false claims for payments to, or improperly retain overpayments from, the governmentNew

Risks Related to Our Business and Operations

1. 06Risks associated with VBC arrangements may negatively impact our business, operations, and financial condition22% rewritten
2. 07An increase in the volume of uninsured patients or deterioration in the collectability of patient responsibility accounts could adversely affect our financial condition and results of operations33% rewritten
3. 08The reimbursement process is complex and may involve delays and other uncertainties, which may adversely affect our business, operations, cash flows, revenues, and earnings
4. 09The information that we or our Medical Groups provide to Medicare Advantage plans and other payers could be inaccurate, incomplete or unsupportable, which could impact risk adjustment scores and ultimately result in harm to our business, operations and financial condition
5. 10Third-party payer controls designed to reduce costs and other payer practices to decrease or review utilization, surgical procedure volumes or reimbursement for services rendered may reduce our revenues
6. 11If the Company and its Medical Groups are unable to effectively compete, our business, financial condition, and results of operations could be adversely impacted
7. 12Our sales and implementation cycle can be long and unpredictable and requires considerable time and expense, which may cause our results of operations to fluctuate
8. 13Our ability to efficiently price the Privia Technology Solution, the Privia Platform, and our Privia operating model could affect our results of operations and our ability to attract or retain Medical Groups, Privia Physicians, health system or hospital partners, ACO participants and payers
9. 14Our performance depends on our ability to contract with Medical Groups, Privia Providers, health system partners, ACO participants and third-party payers
10. 15The success of our business depends on the execution of our growth strategy, which may not prove viable and we may not realize expected results
11. 16We may encounter difficulty acquiring entities or assets, face challenges integrating the operations of acquired businesses or realizing expected results or become liable for unknown or contingent liabilities as a result of acquisitionsNew
12. 17If we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of stakeholder service and patient satisfaction, or adequately address competitive challenges
13. 18If the estimates and assumptions we use to determine the size of our total addressable market, or TAM, are inaccurate, our future growth rate may be impacted and our business could be harmed
14. 19If we are not able to maintain and enhance our reputation and brand recognition, including through the maintenance and protection of trademarks, our business and results of operations will be harmed64% rewritten
15. 20Changes in treatment methodologies, trends related to the usage of primary care and specialist healthcare services, and other factors outside our control that impact demand for medical services may reduce our revenues
16. 21The failure to obtain medical supplies, drugs and other goods for Medical Groups at favorable prices or in sufficient volumes could cause our results of operations to decline45% rewritten

Technology, Cybersecurity and Privacy Risks

1. 22We have, however, experienced limited interruptions in these systems in the past, including temporary slowdowns in the performance of our EMR and the Privia Technology Solution, and we may experience similar or more significant interruptions in the future
2. 23Our business depends on our ability to effectively invest in, implement improvements to and properly maintain our information technology and other business systems29% rewritten
3. 24technology on reasonable terms or obtain similar technology from another source, our revenue and earnings could be adversely impactedNew
4. 25If we are unable to protect the confidentiality of our trade secrets, know-how and other proprietary and internally developed information, the value of our technology could be adversely affected
5. 26Any restrictions on our use of, or ability to license, data, or our failure to license data and integrate third-party technologies, could have a material adverse effect on our business, financial condition and results of operations
6. 27Our use of “open source” software could adversely affect our ability to offer our services and subject us to possible litigation
7. 28We face risks associated with healthcare technology initiatives, including those related to sharing patient data and interoperability, as well as our use of certain AI and machine learning models
8. 29HIPAA further has certain patient notification requirements for breaches or non-permitted use or disclosure of PHI, which include thresholds for reporting to HHS and local media, and such public reporting may also increase the risk of civil suits related to privacy incidents63% rewritten
9. 30any failure by us or our Medical Groups to comply with these and any other comprehensive privacy laws passed at the state or federal level may result in regulatory enforcement action, civil litigation and reputational harmNew

Human Capital Risks

1. 31We depend on our senior management team and other key employees, and the loss of one or more of these employees or an inability to attract, recruit, motivate, develop and retain other highly skilled employees could harm our business
2. 32The operations and growth strategy of the Company and its Medical Groups depend on our ability to recruit and retain qualified talent, including physicians and non-physician practitioners46% rewritten
3. 33Failure to attract and retain talent within our growth and business development teams could impede our growth
4. 34Our corporate culture has contributed to our success, and if we cannot maintain this culture as we grow, we could lose the innovation, creativity and teamwork fostered by our culture and our business may be harmed

Financial Risks

1. 35We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to maintain profitability46% rewritten
2. 36Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations
3. 37We face risks associated with our indebtedness, which could restrict our current and future operations or adversely affect our business and growth prospects74% rewritten
4. 38Our failure to raise additional capital or generate cash flows necessary to expand our operations and invest in new technologies in the future could reduce our ability to compete successfully and harm our results of operations70% rewritten

General Risks

1. 39A deterioration of public health conditions associated with a pandemic, epidemic or outbreak of an infectious disease in the markets in which we operate could adversely impact our business68% rewritten
2. 40Increased attention to, and evolving expectations for, environmental, social, and governance (“ESG”) initiatives could increase our costs, harm our reputation, or otherwise adversely impact our business94% rewritten
3. 41compliance, stakeholder engagement, contracting and insurance), enhanced compliance or disclosure obligations, or other adverse impacts to our business, financial condition, or results of operationsNew

Risks Related to Our Common Stock

1. 42Provisions of our corporate governance documents could make an acquisition of us more difficult and may prevent attempts by our stockholders to replace or remove our current management, even if beneficial to our stockholders26% rewritten
2. 43Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation that may be initiated by our stockholders, which may limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us
3. 44Our operating results and stock price may be volatile, and the market price of our common stock may drop below the price you pay
4. 45Future sales and issuances of our outstanding shares could cause the market price of our common stock to drop significantly, even if our business is doing well
5. 46Because we have no current plans to pay regular cash dividends on our common stock, you may not receive any return on investment unless you sell your common stock for a price greater than that which you paid for it